News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2024 Shelley Wood October 01, 2024
News Daily News Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement Todd Neale September 26, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Daily News Scientific Statement Reviews Current Antithrombotic Options in PAD L.A. McKeown August 26, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2024 Shelley Wood July 31, 2024
News Daily News Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years Yael L. Maxwell June 26, 2024
News Daily News Dramatic LDL Drops Seen in PAD Patients With Team-Based Care L.A. McKeown June 18, 2024
News Conference News ESOC 2024 Thrombectomy’s Benefits in Large-Core Strokes Sustained at 1 Year: TENSION Todd Neale May 22, 2024
News Daily News LASTE Shows Thrombectomy Helps for Large Strokes of All Sizes Todd Neale May 10, 2024
News Conference News SCAI 2024 No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis L.A. McKeown May 10, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2024 Shelley Wood April 30, 2024
News Daily News BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI L.A. McKeown April 24, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Conference News ISC 2024 MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone Todd Neale February 08, 2024